<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vestim</journal-id><journal-title-group><journal-title xml:lang="ru">Известия Национальной  академии наук Беларуси. Серия медицинских наук</journal-title><trans-title-group xml:lang="en"><trans-title>Proceedings of the National Academy of Sciences of Belarus, Medical series</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1814-6023</issn><issn pub-type="epub">2524-2350</issn><publisher><publisher-name>The Republican Unitary Enterprise Publishing House "Belaruskaya Navuka"</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">vestim-216</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ И ЭКСПЕРИМЕНТАЛЬНАЯ МЕДИЦИНА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL AND EXPERIMENTAL MEDICINE</subject></subj-group></article-categories><title-group><article-title>Фармакодинамические взаимодействия редокс-модулирующих аминокислот L-аргинина и таурина с плейотропными антиоксидантами</article-title><trans-title-group xml:lang="en"><trans-title>Pharmacodynamic interactions of the redox modulating amino acids L-arginine and taurine with pleiotropic anti-oxidants</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бизунок</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Bizunok</surname><given-names>N. A.</given-names></name></name-alternatives><email xlink:type="simple">bizunokna@bsmu.by</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Белорусский государственный медицинский университет</institution></aff><aff xml:lang="en"><institution>Belarusian State Medical University</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>06</day><month>06</month><year>2016</year></pub-date><volume>0</volume><issue>4</issue><fpage>68</fpage><lpage>84</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Бизунок Н.А., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Бизунок Н.А.</copyright-holder><copyright-holder xml:lang="en">Bizunok N.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://vestimed.belnauka.by/jour/article/view/216">https://vestimed.belnauka.by/jour/article/view/216</self-uri><abstract><p>М) в молярных соотношениях 1:1-1:100 (CI = 0 ,56-0,04). Компоненты этих комбинаций не только дополняют друг друга по абсолютному антирадикальному спектру и биологической активности, но и взаимно ускоряют радикальные взаимодействия и рассматриваются как основа для разработки новых лекарственных средств цитопротекторного и антиоксидантного действия. Включение в комбинацию дополнительного соединения может альтернативно изменить характер взаимодействия ее компонентов, что свидетельствует о необходимости всестороннего доклинического изучения любых сочетаний лекарственных средств.</p></abstract><trans-abstract xml:lang="en"><p>М) in molar ratios of 1:1-1:100 (CI = 0.56-0.04). The components of such combinations are not only complementary another absolute anti-radical spectrum and biological activity, but also accelerate the radical interaction with each other and are considered as the basis for developing new cytoprotective and antioxidant drugs. It is also shown that the inclusion of an additional component in the synergistic combination can alter the character of the components interaction to antagonism and the resultant biological effect of the combination, which in turn indicates the urgent need for a comprehensive pre-clinical study of any drugs combinations.</p></trans-abstract></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Effects of arginine, L-alanyl-L-glutamine or taurine on neutrophil (PMN) free amino acid profiles and immune functions in vitro / J. Muhling [et al.] // Amino Acids. - 2002. - Vol. 22, N 1. - P. 39-53.</mixed-citation><mixed-citation xml:lang="en">Effects of arginine, L-alanyl-L-glutamine or taurine on neutrophil (PMN) free amino acid profiles and immune functions in vitro / J. Muhling [et al.] // Amino Acids. - 2002. - Vol. 22, N 1. - P. 39-53.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Заволовская, Л. И. Клиническая эффективность тауфона в комбинированном лечении больных с хронической недостаточностью кровообращения / Л. И. Заволовская, Е. П. Елизарова, В. А. Орлов // Эксперим. и клин. фармакол. -1995. - Т. 58. - С. 29-32.</mixed-citation><mixed-citation xml:lang="en">Заволовская, Л. И. Клиническая эффективность тауфона в комбинированном лечении больных с хронической недостаточностью кровообращения / Л. И. Заволовская, Е. П. Елизарова, В. А. Орлов // Эксперим. и клин. фармакол. -1995. - Т. 58. - С. 29-32.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Шестакова, М. В. Опыт применения дибикора при сахарном диабете второго типа / М. В. Шестакова, Л. А. Чугунова, М. Ш. Шахалова // Сахарный диабет. - 2007. - № 1. - С. 30-31.</mixed-citation><mixed-citation xml:lang="en">Шестакова, М. В. Опыт применения дибикора при сахарном диабете второго типа / М. В. Шестакова, Л. А. Чугунова, М. Ш. Шахалова // Сахарный диабет. - 2007. - № 1. - С. 30-31.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Anthrayose, C. V. Studies on protein and taurine in normal, senile and diabetic cataractous human lenses / C. V. Anthrayose, S. Shashidhar // Indian J. Physiol. Pharmacol. - 2004. - Vol. 48, N 3. - Р. 357-360.</mixed-citation><mixed-citation xml:lang="en">Anthrayose, C. V. Studies on protein and taurine in normal, senile and diabetic cataractous human lenses / C. V. Anthrayose, S. Shashidhar // Indian J. Physiol. Pharmacol. - 2004. - Vol. 48, N 3. - Р. 357-360.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">The effect of taurine on the toll-like receptors/nuclear factor kappa B (TLRs/NF-кВ) signaling pathway in Streptococcus uberis-induced mastitis in rats / J. Miaoa [et al.] // Int. Immunopharm. - 2011. - Vol. 11. - Р. 1740-1746.</mixed-citation><mixed-citation xml:lang="en">The effect of taurine on the toll-like receptors/nuclear factor kappa B (TLRs/NF-кВ) signaling pathway in Streptococcus uberis-induced mastitis in rats / J. Miaoa [et al.] // Int. Immunopharm. - 2011. - Vol. 11. - Р. 1740-1746.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Chou, T.-Ch. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies / T.-Ch. Chou // Pharmacol. Rev. - 2006. - Vol. 58. - Р. 621-681.</mixed-citation><mixed-citation xml:lang="en">Chou, T.-Ch. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies / T.-Ch. Chou // Pharmacol. Rev. - 2006. - Vol. 58. - Р. 621-681.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Bizunok, N. A. Theory of pleiotropic action of biologically active compounds and medicines - basic principles and practical application / N. A. Bizunok // Open J. of Clin. Diagnostics. - 2013. - Vol. 3, N 3. - P. 94-104.</mixed-citation><mixed-citation xml:lang="en">Bizunok, N. A. Theory of pleiotropic action of biologically active compounds and medicines - basic principles and practical application / N. A. Bizunok // Open J. of Clin. Diagnostics. - 2013. - Vol. 3, N 3. - P. 94-104.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Бизунок, Н. А. Плейотропное действие модуляторов клеточных функций на макрофагальную генерацию активных форм кислорода при FcR-зависимом фагоцитозе / Н. А. Бизунок // Мед. журн. - 2013. - № 2. - С. 44-47.</mixed-citation><mixed-citation xml:lang="en">Бизунок, Н. А. Плейотропное действие модуляторов клеточных функций на макрофагальную генерацию активных форм кислорода при FcR-зависимом фагоцитозе / Н. А. Бизунок // Мед. журн. - 2013. - № 2. - С. 44-47.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Дубовик, Б. В. Синергичные иммунотропные взаимодействия компонента красного вина транс-ресвератрола, антиоксиданта аскорбата и гормона мелатонина на модели респираторного взрыва макрофагов / Б. В. Дубовик, Н. А. Бизунок // Мед. журн. - 2011. - № 3. - С. 52-61.</mixed-citation><mixed-citation xml:lang="en">Дубовик, Б. В. Синергичные иммунотропные взаимодействия компонента красного вина транс-ресвератрола, антиоксиданта аскорбата и гормона мелатонина на модели респираторного взрыва макрофагов / Б. В. Дубовик, Н. А. Бизунок // Мед. журн. - 2011. - № 3. - С. 52-61.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Opie, L. H. The red wine hypothesis: from concepts to protective signalling molecules / L. H. Opie, S. Lecour // Eur. Heart J. - 2007. - Vol. 28. - P. 1683-1693.</mixed-citation><mixed-citation xml:lang="en">Opie, L. H. The red wine hypothesis: from concepts to protective signalling molecules / L. H. Opie, S. Lecour // Eur. Heart J. - 2007. - Vol. 28. - P. 1683-1693.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Resveratrol attenuates oxLDL-stimulated NADPH oxidase activity and protects endothelial cells from oxidative functional damages / Shu-Er Chow [et al.] // J. Appl. Physiol. - 2007. - Vol. 102. - P. 1520-1527.</mixed-citation><mixed-citation xml:lang="en">Resveratrol attenuates oxLDL-stimulated NADPH oxidase activity and protects endothelial cells from oxidative functional damages / Shu-Er Chow [et al.] // J. Appl. Physiol. - 2007. - Vol. 102. - P. 1520-1527.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ximenes, V. F. Superoxide-dependent oxidation of melatonin by myeloperoxidase // V. F. Ximenes [et al.] // J. Biol. Chem. - 2005. - Vol. 280, N 46. - Р. 38160-38169.</mixed-citation><mixed-citation xml:lang="en">Ximenes, V. F. Superoxide-dependent oxidation of melatonin by myeloperoxidase // V. F. Ximenes [et al.] // J. Biol. Chem. - 2005. - Vol. 280, N 46. - Р. 38160-38169.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans / R. J. Reiter [et al.] // Acta Biochim. Polonica. - 2003. - Vol. 50, N 4. - P. 1129-1146.</mixed-citation><mixed-citation xml:lang="en">Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans / R. J. Reiter [et al.] // Acta Biochim. Polonica. - 2003. - Vol. 50, N 4. - P. 1129-1146.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Зозуля, Ю. А. Свободнорадикальное окисление и антиоксидантная защита при патологии головного мозга / Ю. А. Зозуля, В. А. Барабой, Д. А. Сутковой. - М.: Знание-М, 2000. - 344 с.</mixed-citation><mixed-citation xml:lang="en">Зозуля, Ю. А. Свободнорадикальное окисление и антиоксидантная защита при патологии головного мозга / Ю. А. Зозуля, В. А. Барабой, Д. А. Сутковой. - М.: Знание-М, 2000. - 344 с.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopoly-saccharide-induced multiple organ dysfunction syndrome in rats / E. Crespo [et al.] // FASEB J. - 1999. - Vol. 13, N 12. -P. 1537-1546.</mixed-citation><mixed-citation xml:lang="en">Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopoly-saccharide-induced multiple organ dysfunction syndrome in rats / E. Crespo [et al.] // FASEB J. - 1999. - Vol. 13, N 12. -P. 1537-1546.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: role of inhibition of NFkB activation / E. Gilad [et al.] // FASEB J. - 1998. - Vol. 12. - P. 685-693.</mixed-citation><mixed-citation xml:lang="en">Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: role of inhibition of NFkB activation / E. Gilad [et al.] // FASEB J. - 1998. - Vol. 12. - P. 685-693.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, Classification, and Pharmacology of G Protein-Coupled Melatonin Receptors / M. L. Dubocovich [et al.] // Pharmacol. Rev. - 2010. - Vol. 62. - Р. 343-380.</mixed-citation><mixed-citation xml:lang="en">International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, Classification, and Pharmacology of G Protein-Coupled Melatonin Receptors / M. L. Dubocovich [et al.] // Pharmacol. Rev. - 2010. - Vol. 62. - Р. 343-380.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Expression of membrane and nuclear melatonin receptor mRNA and protein in the mouse immune system / A. Car-rillo-Vico [et al.] // Cell. and Mol. Life Sci. (CMLS). - 2003. - Vol. 60, N 10. - P. 2272-2278.</mixed-citation><mixed-citation xml:lang="en">Expression of membrane and nuclear melatonin receptor mRNA and protein in the mouse immune system / A. Car-rillo-Vico [et al.] // Cell. and Mol. Life Sci. (CMLS). - 2003. - Vol. 60, N 10. - P. 2272-2278.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Guerrero, J. M. Melatonin-immune system relationships / J. M. Guerrero, R. J. Reiter // Curr. Top. Med. Chem. -2002. - Vol. 2. - Р. 167-179.</mixed-citation><mixed-citation xml:lang="en">Guerrero, J. M. Melatonin-immune system relationships / J. M. Guerrero, R. J. Reiter // Curr. Top. Med. Chem. -2002. - Vol. 2. - Р. 167-179.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Correlation between nuclear melatonin receptor expression and enhanced cytokine production in human lymphocytic and monocytic cell lines / S. Garcia-Maurmo [et al.] // J. Pineal Res. - 2000. - Vol. 29, N 3. - P. 129-137.</mixed-citation><mixed-citation xml:lang="en">Correlation between nuclear melatonin receptor expression and enhanced cytokine production in human lymphocytic and monocytic cell lines / S. Garcia-Maurmo [et al.] // J. Pineal Res. - 2000. - Vol. 29, N 3. - P. 129-137.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Free radical mediated molecular damage: mechanisms of melatonin's protective actions in the central nervous system / R. J. Reiter [et al.] // Ann. N. Y. Acad. Sci. - 2001. - Vol. 939, N 1. - P. 200-215.</mixed-citation><mixed-citation xml:lang="en">Free radical mediated molecular damage: mechanisms of melatonin's protective actions in the central nervous system / R. J. Reiter [et al.] // Ann. N. Y. Acad. Sci. - 2001. - Vol. 939, N 1. - P. 200-215.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Functional and analytical evidence for scavenging of oxygen radicals by L-arginine / A. Lass [et al.] // Mol. pharmacol. - 2002. - Vol. 61, N 5. - P. 1081-1088.</mixed-citation><mixed-citation xml:lang="en">Functional and analytical evidence for scavenging of oxygen radicals by L-arginine / A. Lass [et al.] // Mol. pharmacol. - 2002. - Vol. 61, N 5. - P. 1081-1088.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Taurine chloramine inhibits inducible nitric oxide synthase and TNF-a gene expression in activated alveolar macro-phages: decreased NF-kB activation and IkB kinase activity / M. Barua [et al.] // J. Immunol. - 2001. - Vol. 167. - P. 2275-2281.</mixed-citation><mixed-citation xml:lang="en">Taurine chloramine inhibits inducible nitric oxide synthase and TNF-a gene expression in activated alveolar macro-phages: decreased NF-kB activation and IkB kinase activity / M. Barua [et al.] // J. Immunol. - 2001. - Vol. 167. - P. 2275-2281.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">The antioxidant action of taurine, hypotaurine, and their metabolic precursors / O. I. Aruoma [et al.] // Biochem. J. -1988. - Vol. 256. - P. 251-255.</mixed-citation><mixed-citation xml:lang="en">The antioxidant action of taurine, hypotaurine, and their metabolic precursors / O. I. Aruoma [et al.] // Biochem. J. -1988. - Vol. 256. - P. 251-255.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Jones, D. P. Radical-free biology of oxidative stress / D. P. Jones // Am. J. Physiol. Cell Physiol. - 2008. - Vol. 295. -Р. C849-C868.</mixed-citation><mixed-citation xml:lang="en">Jones, D. P. Radical-free biology of oxidative stress / D. P. Jones // Am. J. Physiol. Cell Physiol. - 2008. - Vol. 295. -Р. C849-C868.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Копелевич, В. М. Витаминоподобные соединения L-карнитин и ацетил^-карнитин: от биохим. исслед. к мед. применению / В. М. Копелевич // Укр. биохим. журн. - 2005. - Т. 77, № 4. - С. 30-50.</mixed-citation><mixed-citation xml:lang="en">Копелевич, В. М. Витаминоподобные соединения L-карнитин и ацетил^-карнитин: от биохим. исслед. к мед. применению / В. М. Копелевич // Укр. биохим. журн. - 2005. - Т. 77, № 4. - С. 30-50.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Ames, B. N. Delaying the mitochondrial decay of aging with acetylcarnitine / B. N. Ames, J. Liu // Ann. N. Y. Acad. Sci. - 2004. - Vol. 1033. - P. 108-116.</mixed-citation><mixed-citation xml:lang="en">Ames, B. N. Delaying the mitochondrial decay of aging with acetylcarnitine / B. N. Ames, J. Liu // Ann. N. Y. Acad. Sci. - 2004. - Vol. 1033. - P. 108-116.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Acetyl-L-carnitine ameliorates hypobaric hypoxic impairment and spatial memory deficits in rats / K. Barhwal [et al.] // Eur. J. Pharmacol. - 2007. - Vol. 570. - P. 97-107.</mixed-citation><mixed-citation xml:lang="en">Acetyl-L-carnitine ameliorates hypobaric hypoxic impairment and spatial memory deficits in rats / K. Barhwal [et al.] // Eur. J. Pharmacol. - 2007. - Vol. 570. - P. 97-107.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Effect of ICV taurine on the impairment of learning, convulsions and death caused by hypoxia / M. Malcangio [et al.] // Psychopharmacology. - 1989. - Vol. 98, N 3. - P. 316-320.</mixed-citation><mixed-citation xml:lang="en">Effect of ICV taurine on the impairment of learning, convulsions and death caused by hypoxia / M. Malcangio [et al.] // Psychopharmacology. - 1989. - Vol. 98, N 3. - P. 316-320.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Saransaari, P. Taurine and neural cell damage / P. Saransaari, S. S. Oja // Amino Acids. - 2000. - Vol. 19, N 3-4. - P. 509-526.</mixed-citation><mixed-citation xml:lang="en">Saransaari, P. Taurine and neural cell damage / P. Saransaari, S. S. Oja // Amino Acids. - 2000. - Vol. 19, N 3-4. - P. 509-526.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Vohra, B. P. Improvement of impaired memory in mice by taurine / B. P. Vohra, X. Hui // Neural Plast. - 2000. - Vol. 7, N 4. - P. 245-259.</mixed-citation><mixed-citation xml:lang="en">Vohra, B. P. Improvement of impaired memory in mice by taurine / B. P. Vohra, X. Hui // Neural Plast. - 2000. - Vol. 7, N 4. - P. 245-259.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-L-carni-tine / G. Bianchi [et al.] // Eur. J. Cancer. - 2005. - Vol. 41. - P. 1746-1750.</mixed-citation><mixed-citation xml:lang="en">Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-L-carni-tine / G. Bianchi [et al.] // Eur. J. Cancer. - 2005. - Vol. 41. - P. 1746-1750.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Acetyl-L-carnitine administration increases insulin-like growth factor 1 levels in asymptomatic HIV-1-infected subjects correlation with its suppressive effect on lymphocyte apoptosis and ceramide generation / L. Di Marzio [et al.] // Clin. Immunol. - 1999. - Vol. 92. - P. 103-110.</mixed-citation><mixed-citation xml:lang="en">Acetyl-L-carnitine administration increases insulin-like growth factor 1 levels in asymptomatic HIV-1-infected subjects correlation with its suppressive effect on lymphocyte apoptosis and ceramide generation / L. Di Marzio [et al.] // Clin. Immunol. - 1999. - Vol. 92. - P. 103-110.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Kim, C. Production of reactive oxygen and nitrogen species in phagocytes is regulated by taurine chloramines / C. Kim, Y. N. Cha. // Adv. Exp. Med. Biol. - 2009. - Vol. 643. - P. 463-472.</mixed-citation><mixed-citation xml:lang="en">Kim, C. Production of reactive oxygen and nitrogen species in phagocytes is regulated by taurine chloramines / C. Kim, Y. N. Cha. // Adv. Exp. Med. Biol. - 2009. - Vol. 643. - P. 463-472.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Antimicrobial and cytotoxic activity of hypochlorous acid: interactions with taurine and nitrite / J. Marcinkiewicz [et al.] // J. Inflamm. Res. - 2000. - Vol. 49, N 6. - P. 280-289.</mixed-citation><mixed-citation xml:lang="en">Antimicrobial and cytotoxic activity of hypochlorous acid: interactions with taurine and nitrite / J. Marcinkiewicz [et al.] // J. Inflamm. Res. - 2000. - Vol. 49, N 6. - P. 280-289.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Acute effects of acetyl-L-carnitine on regional cerebral blood flow in patients with brain ischemia / G. Rosadini [et al.] // Int. J. Clin. Pharmacol. Res. - 1990. - Vol. 10. - P. 123-128.</mixed-citation><mixed-citation xml:lang="en">Acute effects of acetyl-L-carnitine on regional cerebral blood flow in patients with brain ischemia / G. Rosadini [et al.] // Int. J. Clin. Pharmacol. Res. - 1990. - Vol. 10. - P. 123-128.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Acetylcarnitine and cellular stress response: roles in nutritional redox homeostasis and regulation of longevity genes / V. Calabrese [et al.] // J. Nutr. Biochem. - 2006. - Vol. 17, N 2. - P. 73-88.</mixed-citation><mixed-citation xml:lang="en">Acetylcarnitine and cellular stress response: roles in nutritional redox homeostasis and regulation of longevity genes / V. Calabrese [et al.] // J. Nutr. Biochem. - 2006. - Vol. 17, N 2. - P. 73-88.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Antioxidant role and subcellular location of hypotaurine and taurine in human neutrophils / T. R. Green [et al.] // Biochim. Biophys. Acta. - 1991. - Vol. 1073. - P. 91-97.</mixed-citation><mixed-citation xml:lang="en">Antioxidant role and subcellular location of hypotaurine and taurine in human neutrophils / T. R. Green [et al.] // Biochim. Biophys. Acta. - 1991. - Vol. 1073. - P. 91-97.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Reactivity of taurine with aldehydes and its physiological role / M. Ogasawara [et al.] // Chem. Pharm. Bull. - 1993. -Vol. 41. - P. 2172-2175.</mixed-citation><mixed-citation xml:lang="en">Reactivity of taurine with aldehydes and its physiological role / M. Ogasawara [et al.] // Chem. Pharm. Bull. - 1993. -Vol. 41. - P. 2172-2175.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">The sympathetic nerve - an integrative interface between two supersysrems: the brain and the immune system / I. J. Elenkov [et al.] // Pharmacol. Rev. - 2000. - Vol. 52. - P. 595-638.</mixed-citation><mixed-citation xml:lang="en">The sympathetic nerve - an integrative interface between two supersysrems: the brain and the immune system / I. J. Elenkov [et al.] // Pharmacol. Rev. - 2000. - Vol. 52. - P. 595-638.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Wu, J.-Y. Role of taurine in the central nervous system / J.-Y. Wu, H. Prentice // J. Biomed. Sci. - 2010. - Vol. 17 (Suppl. 1). - Режим доступа: http://www.jbiomedsci.com/content/pdf/1423-0127-17-S1-S1.pdf. - Дата доступа: 24.08.2010.</mixed-citation><mixed-citation xml:lang="en">Wu, J.-Y. Role of taurine in the central nervous system / J.-Y. Wu, H. Prentice // J. Biomed. Sci. - 2010. - Vol. 17 (Suppl. 1). - Режим доступа: http://www.jbiomedsci.com/content/pdf/1423-0127-17-S1-S1.pdf. - Дата доступа: 24.08.2010.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
